← Ticker index
SUPN
Ticker
SUPN
Congressional Trades
13
by 2 members
Ticker disclosure brief
Congressional disclosure records for SUPN
A ticker-first view of recent disclosures, reported ranges, filing lags, party aggregates, federal awards, lobbying records, and source-linked receipts.
Latest receipt
Gilbert Cisneros
BUY · 2026-03-03
Largest range
$1K – $15K
Gilbert Cisneros
Longest observed gap
41d
Gilbert Cisneros
Highest 30d vs SPY
30.3%
Gilbert Cisneros
Purchase rows
9
69%
Sale rows
3
23%
Disclosed midpoint
$104K
range estimate
Unique Traders
2
members
Disclosure timing method
Observed filing gaps are not notice-date findings
The reporting deadline is the earlier of 30 days after notice or 45 days after the transaction. Public disclosure rows provide transaction and filing dates, but do not establish when a member received notice. PoliWealth therefore marks only transaction-to-filing gaps over 45 days as an apparent delay for review; 31–45 day gaps are not labeled late from transaction date alone.
Party Breakdown
Democrats13 · 100%
Republicans0 · 0%
Lobbying filings
all →- 2026-04-20$20KSUPERNUS PHARMACEUTICALS INCissues related to the pharmaceutical industry issues related to Medicare drug reimbursement
- 2026-03-12$20KSUPERNUS PHARMACEUTICALS INCissues related to the pharmaceutical industry issues related to Medicare drug reimbursement
- 2026-03-09$20KSUPERNUS PHARMACEUTICALS INCissues related to the pharmaceutical industry issues related to Medicare drug reimbursement
- 2026-01-20$50KSUPERNUS PHARMACEUTICALS FKA SAGE THERAPEUTICSEducation and awareness of mental health issues especially as it relates to access for postpartum depression treatment and major depressive disorder.
- 2026-01-20$20KSUPERNUS PHARMACEUTICALS INCissues related to the pharmaceutical industry issues related to Medicare drug reimbursement
- 2025-10-20$20KSUPERNUS PHARMACEUTICALS INCissues related to the pharmaceutical industry issues related to Medicare drug reimbursement
- 2025-09-25$20KSUPERNUS PHARMACEUTICALS INCissues related to the pharmaceutical industry issues related to Medicare drug reimbursement
- 2025-07-18$20KSUPERNUS PHARMACEUTICALS INCissues related to the pharmaceutical industry issues related to Medicare drug reimbursement
- 2025-04-15$20KSUPERNUS PHARMACEUTICALS INCissues related to the pharmaceutical industry issues related to Medicare drug reimbursement
Loading trade analytics…
All Disclosed Trades
Page 1 · 13 of 13 shown| Date | Member | Action | Amount | Observed Gap | Receipt |
|---|---|---|---|---|---|
| 2026-03-03 | DGilbert Cisneros | BUY | $1K – $15K | 36d | receipt → |
| 2026-03-03 | DGilbert Cisneros | BUY | $1K – $15K | 36d | receipt → |
| 2026-03-03 | DGilbert Cisneros | BUY | $1K – $15K | 35d | receipt → |
| 2026-03-03 | DGilbert Cisneros | BUY | $1K – $15K | 35d | receipt → |
| 2025-12-11 | DGilbert Cisneros | BUY | $1K – $15K | 33d | receipt → |
| 2025-12-11 | DGilbert Cisneros | BUY | $1K – $15K | 32d | receipt → |
| 2025-12-11 | DGilbert Cisneros | BUY | $1K – $15K | 32d | receipt → |
| 2025-10-09 | DGilbert Cisneros | SELL | $1K – $15K | 41d | receipt → |
| 2025-10-09 | DGilbert Cisneros | SELL | $1K – $15K | 40d | receipt → |
| 2025-10-09 | DGilbert Cisneros | SELL | $1K – $15K | 40d | receipt → |
| 2025-03-24 | DGilbert Cisneros | BUY | $1K – $15K | 14d | receipt → |
| 2025-03-24 | DGilbert Cisneros | BUY | $1K – $15K | 14d | receipt → |
| 2022-12-23 | DJosh Gottheimer | PARTIAL_SELL | $1K – $15K | 12d | receipt → |
“Observed gap” is the calendar distance from transaction date to filing date; only gaps over 45 days receive an apparent-delay marker.